Sarepta Therapeutics
SRPT
SRPT
423 hedge funds and large institutions have $11.2B invested in Sarepta Therapeutics in 2023 Q1 according to their latest regulatory filings, with 69 funds opening new positions, 150 increasing their positions, 134 reducing their positions, and 52 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
2.44% more ownership
Funds ownership: 89.86% → 92.31% (+2.4%)
5% more call options, than puts
Call options by funds: $489M | Put options by funds: $467M
8% less funds holding in top 10
Funds holding in top 10: 13 → 12 (-1)
Holders
423
Holding in Top 10
12
Calls
$489M
Puts
$467M
Top Buyers
| 1 | +$339M | |
| 2 | +$107M | |
| 3 | +$78M | |
| 4 |
ACA
Avoro Capital Advisors
New York
|
+$65.5M |
| 5 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$60.4M |
Top Sellers
| 1 | -$176M | |
| 2 | -$154M | |
| 3 | -$90.3M | |
| 4 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$88.1M |
| 5 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$68.9M |